Nanocarry Therapeutics
- Biotech or pharma, therapeutic R&D
Nanocarry Therapeutics is developing a novel platform for delivering therapeutics across the blood-brain barrier to treat brain cancers and CNS diseases. Our lead candidate, AxS007, targets breast cancer brain metastases with antibody-based therapy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}